Latest filing published 30 Jan 2026 for SENSORION, €3.0M. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Sofinnova Partners SAS is a declared insider at 5 companies; the most frequent names are Abivax, Gensight Biologics S.A. and Sensorion. Between 16 February 2021 and 28 January 2026, the trades on record add up to 32 filings.
The open-market side counts 2 purchases for €6.7M alongside 6 sales for €204.8M. On balance, insiders were net sellers of €198.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 30 January 2026: a transaction of €3.0M, in Sensorion. The last purchase on record was published on 6 September 2022, which is 1,502 days ago. Filings reach the AMF feed a median of 5 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations